Hello,
As the summer months progress, the IASLC is busy preparing for upcoming meetings, celebrating the growth in our journals, and working toward equity and inclusion for all IASLC members. We are excited to share this growth with you.
The Journal of Thoracic Oncology continues to hold a significant impact in the lung cancer community. The JTO features novel research about the prevention, detection, diagnosis, and treatment of all thoracic malignancies. The IASLC is excited to announce that the JTO’s impact factor increased from 13.357 in 2019 to 15.609 in 2020. The journal now ranks 13th out of all 242 oncology journals and 4th out of all 64 respiratory system journals and continues to have a quick turn-around time, a fast-track category, publish on acceptance (within five days), and promotion of select articles via social media and press releases. Thank you to Dr. Adjei, Mary Todd, Vun-Sin Lim, and the entire JTO Editorial Committee for their leadership and steadfast efforts. Congratulations on a job well done.
The World Conference on Lung Cancer will take place September 8-14 as a worldwide virtual event. The WCLC is the IASLC’s signature event, and we look forward to sharing the latest advances in lung and thoracic oncology through expert lectures, plenary sessions, and live Q&A discussions. On the conference website, you can view the program, register, and view additional conference information. The early registration deadline is July 30.
Registration for the IASLC Hot Topic meeting: Small Cell Lung Cancer will open soon. The meeting will be held as a Worldwide Virtual Event on October 29-30. It will focus on preclinical and clinical advances in small cell lung cancer research, including basic research on oncogenesis and biology of disease, preclinical therapeutic research, and highlights of ongoing clinical translation. Visit https://www.iaslc.org/SCLC-2021 to view the program and learn more.
We are pleased to share that the IASLC has released the IASLC Language Guide. The guide has been developed by members of the IASLC to provide guidelines on best practices with common phrases used during presentations at IASLC conferences and within submitted abstracts. You can download the guide at https://www.iaslc.org/IASLCLanguageGuide.
As you likely know by now, I will be leaving the IASLC on August 31. Serving the IASLC, first as its Managing Director and then as CEO, has been a professional highlight for me.
One of the core strengths of the IASLC I always cherished is its sense of community. This community includes each of you, our members, staff, partners, and supporters. I am grateful that I have been able to be part of this community and to contribute to its compelling mission. Together, over the past 3+ years, we made great progress, to include the continued delivery of our myriad educational and scientific programs, journals, publications, and advocacy work as well as our leadership in the Lung Ambition Alliance. We also made important investments in our operations to include membership and financial systems, new website, new office space, and staff capacity and culture. Together, we also weathered a pandemic, all while positioning the IASLC for the future.
Thank you to the talented and committed members and supporters who have contributed to our shared success. There are frankly too many of you to thank individually. Two people though that I would like to recognize are Prof. Giorgio Scagliotti and Prof. Tetsuya Mitsudomi. Giorgio, thank you for your unwavering support and dedication to this organization as well as your mentorship and friendship. And, thank you Tetsuya, for your kindness and unwavering support. I am indebted to both of you.
Finally, I want to thank the IASLC staff for their talents, resilience, and commitment. I am grateful to have had the opportunity to work alongside you. Keep up the great work!
With my very best wishes,
Dave